Ocular surgery News
PARIS — The inject-and-extend schedule for anti-VEGF therapy with ranibizumab in age-related macular degeneration shows better efficacy and compatibility with patients' lifestyles and needs than the as-needed regimen, according to a study carried out at two clinics in France.